Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 known ✓ | P00915 | 2/20 | 0.40 |
| ▸ | CA2 known ✓ | P00918 | 2/20 | 0.40 |
| ▸ | CA12 known ✓ | O43570 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.42 |
| ▸ | HTR6 | P50406 | 1/20 | 0.41 |
| ▸ | HPRT1 | P00492 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | TTR | P02766 | 1/20 | 0.38 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.38 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29706503 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TSHRHSD17B10CYP3A4HPGD | |
| SCHEMBL8610190 | 0.96 | ALDH1A1 (0.42) | ALDH1A1TSHRHSD17B10CYP3A4HPGD | |
| Potassium Ion SCHEMBL5696234 | 0.96 | ALDH1A1 (0.42) | ALDH1A1TSHRHSD17B10CYP3A4HPGD | |
| SCHEMBL2539474 | 0.81 | CA1 (0.52) | ALDH1A1TSHRHSD17B10CYP3A4HPGD | |
| SCHEMBL17685470 | 0.80 | NR1I2 (0.39) | ALDH1A1TSHRHSD17B10CYP3A4HPGD | |
| SCHEMBL313224 | 0.79 | CYP2D6 (0.46) | ALDH1A1TSHRHSD17B10CYP3A4HPGD | |
| SCHEMBL9840761 | 0.79 | ALDH1A1 (0.43) | ALDH1A1TSHRHSD17B10CYP3A4HPGD | |
| SCHEMBL3233249 | 0.79 | CA1 (0.41) | ALDH1A1TSHRHSD17B10HTR6HPRT1 | |
| SCHEMBL10904716 | 0.79 | HPRT1 (0.46) | ALDH1A1TSHRHSD17B10CYP3A4HPGD | |
| SCHEMBL4314621 | 0.79 | CA1 (0.41) | ALDH1A1TSHRHSD17B10HTR6HPRT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114621546-B | Heat dissipation film, composite heat dissipation fin and preparation method thereof | 上海天马微电子有限公司 | 2023-10-27 | — | — | CN | claimed |
| CN-115261995-B | Crystal face micro-structuring auxiliary agent and preparation method thereof | 陕西科技大学 | 2023-07-21 | — | — | CN | claimed |
| CN-114621546-A | Heat dissipation film, composite heat dissipation fin and preparation method of composite heat dissipation fin | 上海天马微电子有限公司 | 2022-06-14 | — | — | CN | claimed |
| CN-114351257-A | Additive for rapid texturing of HIT solar cell and texturing process | 嘉兴市小辰光伏科技有限公司 | 2022-04-15 | — | — | CN | claimed |
| US-5035970-A | Encapsulated toner compositions and processes thereof | XEROX CORPORATION (US) | 1991-07-30 | — | — | US | claimed |
| US-20250223462-A1 | ELECTRONIC COMPONENT | NIHON PARKERIZING CO., LTD. (JP) | 2025-07-10 | — | — | US | disclosed |
| US-20240000084-A1 | ANTIPATHOGENIC AGENT, ANTIBACTERIAL AGENT, ANTIVIRAL AGENT, PATHOGEN DISPOSAL DEVICE, ANTIPATHOGENIC AGENT PRODUCTION METHOD, ANTIBACTERIAL TREATMENT METHOD, VIRUS INACTIVATION METHOD, AND PATHOGEN DISPOSAL METHOD | ACENET INC. (JP) | 2024-01-04 | — | — | US | disclosed |
| WO-2023195439-A1 | ELECTRONIC COMPONENT | 日本パーカライジング株式会社 | 2023-10-12 | — | — | WO | disclosed |
| WO-2023190598-A1 | COMPOSITION | アース製薬株式会社 | 2023-10-05 | — | — | WO | disclosed |
| CN-113698323-B | Method for producing tobias acid by reducing yield of acid precipitation mother liquor wastewater | 昌邑瑞新化学工业有限公司 | 2023-09-05 | — | — | CN | disclosed |
| US-20230263710-A1 | ORAL CARE AGENT | OSAKA UNIVERSITY (JP) | 2023-08-24 | — | — | US | disclosed |
| EP-4230042-A1 | ANTIPATHOGENIC DRUG, ANTIBACTERIAL AGENT, ANTIVIRAL AGENT, PATHOGEN PROCESSING DEVICE, METHOD FOR PRODUCING ANTIPATHOGENIC DRUG, ANTIBACTERIAL METHOD, VIRUS INACTIVATION METHOD, AND PATHOGEN PROCESSING METHOD | Acenet Inc. (JP) | 2023-08-23 | — | — | EP | disclosed |
| US-7041421-B2 | Laked azo red pigment and processes for preparation and use | ENGELHARD CORPORATION (US) | 2006-05-09 | — | — | US | disclosed |
| US-6902612-B2 | Heat stable laked monoazo red pigment | ENGELHARD CORPORATION (US) | 2005-06-07 | — | — | US | disclosed |
| WO-2005026264-A1 | HEAT STABLE LAKED MONOAZO RED PIGMENT | ENGELHARD CORPORATION (US) | 2005-03-24 | — | — | WO | disclosed |
| WO-2005026265-A1 | LAKED AZO RED PIGMENT AND PROCESSES FOR PREPARATION AND USE | ENGELHARD CORPORATION (US) | 2005-03-24 | — | — | WO | disclosed |
| US-20050054385-A1 | Laked azo red pigment and processes for preparation and use | ENGELHARD CORPORATION | 2005-03-10 | — | — | US | disclosed |
| US-20050051050-A1 | Heat stable laked monoazo red pigment | ENGELHARD CORPORATION | 2005-03-10 | — | — | US | disclosed |
| US-6274714-B1 | REACTING 1,2-NAPHTHOQUINONE-2-DIAZIDE WITH CHLOROSULFURIC ACID; THEN THIONYL CHLORIDE OR PHOSPHORUS PENTACHLORIDE | TOYO GOSEI KOGYO CO., LTD. (JP) | 2001-08-14 | — | — | US | disclosed |
| EP-1044964-A2 | Method for producing 1,2-naphthoquinone-2-diazide-4-sulphonyl chloride | Toyo Gosei Kogyo Co., Ltd. (JP) | 2000-10-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230263710-A1 | ORAL CARE AGENT | TAS2R39, TAS2R40, TAS2R45 | CA1 2268/4885CA2 1770/4885CA12 660/4885 |
| US-20240000084-A1 | ANTIPATHOGENIC AGENT, ANTIBACTERIAL AGENT, ANTIVIRAL AGENT, PATHOGEN DISPOSAL DEVICE, ANTIPATHOGENIC AGENT PRODUCTION METHOD, ANTIBACTERIAL TREATMENT METHOD, VIRUS INACTIVATION METHOD, AND PATHOGEN DISPOSAL METHOD | EIF2AK2, HAO2, ZC3HAV1 | CA1 3911/4885CA2 2225/4885CA12 2256/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.